article thumbnail

Metabolon introduces ‘groundbreaking’ bioinformatics platform

Outsourcing Pharma

a prominent figure in metabolomics solutions, has launched a seminal integrated bioinformatics platform, aiming to redefine metabolomics analysis in life sciences research. Metabolon, Inc.,

article thumbnail

CancerVar: A New Bioinformatics Tool Developed for Clinical Interpretation of Cancer Mutations

XTalks

CancerVar will help researchers standardize and automate clinical interpretations for 13 million somatic mutations from 1,911 cancer census genes. CancerVar will help researchers standardize and automate clinical interpretations for 13 million somatic mutations from 1,911 cancer census genes. Why Was CancerVar Developed?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Absci and M2GEN partner to expedite cancer drug development

Pharmaceutical Technology

Absci has collaborated with bioinformatics firm M2GEN to expedite the development of new cancer medicines. Absci stated that this collaboration combines AI drug creation technology and oncology bioinformatics, thereby reducing the time and cost of cancer drug development.

article thumbnail

Bioinformatics Jobs: How to Succeed in This Competitive Space

XTalks

Bioinformaticians use a combination of mathematics, computer science and biology to help scientists make sense of the data gathered from research projects. The Human Genome Project could not have succeeded without the use of bioinformatics. Wondering which bioinformatics job is right for you? Bioinformatics Analyst.

article thumbnail

Rensselaer team receives NIAID grant to develop antiviral drug for Covid-19

Pharmaceutical Technology

Researchers at the Rensselaer Polytechnic Institute in the US have received a five-year, $3.5m grant from the National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) for developing a Covid-19 oral antiviral drug. Those drugs that hinder only CLpro did not enhance the effects of remdesivir.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. Kim recognised then, he said, that better tools for medicine needed to be developed, and that they still do. Human-first precision health.

article thumbnail

Next-gen bioinformatics tool enables big data analysis without programming expertise

Scienmag

DrBioRight uses natural-language interface to facilitate intuitive data analysis for broader research community Credit: The University of Texas MD Anderson Cancer Center HOUSTON — A new data analysis tool developed by researchers at The University of Texas MD Anderson Cancer Center incorporates a user-friendly, natural-language interface to allow (..)